News

22.06.20 Medannex presents data on its immunomodulatory anticancer agent MDX-124 at AACR Annual Meeting
15.06.20 Medannex announces Innovate UK grant award for novel cancer therapeutic development
10.03.20 Medannex announces new immunomodulatory approach to cancer treatment at Nature conference
16.02.20 Medannex shortlisted in two categories at Scotland’s Life Sciences Awards
02.11.19 Dr Stefan Symeonides to guide Medannex’s Phase I trial preparation
02.10.19 Medannex begins cell line development at FUJIFILM Diosynth
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5